Caspofungin acetate
Key facts
| Invented name |
|
| Active substance |
caspofungin acetate
|
| Therapeutic area |
Infectious diseases
|
| Decision number |
P/30/2008
|
| PIP number |
Caspofungin acetate
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Fungal infections
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
Merck Sharp & Dohme (Europe) Ltd
|
| Decision type |
PM: decision on the application for modification of an agreed PIP
|
| Compliance procedure number |
EMEA-C-000010-PIP01-07-M01
|
| Compliance opinion date |
04/06/2008
|
| Compliance outcome |
positive
|